COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,009 Articles (22,627 medRxiv, 8,382 bioRxiv)

Most recent first Previous |  Page 426: Articles 4251-4260  | Next

Coronavirus pathogenesis in mice explains the SARS-CoV-2 multi-organ spread by red blood cell hitch-hiking
Toro, A., Arevalo, A. P., Pereira-Gomez, M., Sabater, A., Zizzi, E. A., Pascual, G., Lage-Vickers, S., Porfido, J. L., Achinelli, I., Seniuk, R., Bizzotto, J., Moreno, P., Costabile, A., Fajardo, A., Rodriguez, F., Nin, N., Sanchis, P., Anselmino, N., Estefania, L., Cotignola, J., Navone, N., Alonso, D., Vazquez, E., Gentile, F., Cherkasov, A., Moratorio, G., Crispo, M., Gueron, G.
10.1101/2023.03.29.23287591 — Posted: 2023-03-29
Timing and magnitude of the next wave of COVID-19 in China:lessons from 189 countries and territories
Niu, B., Ji, S., Zhao, S., Lei, H.
10.1101/2023.03.27.23287793 — Posted: 2023-03-29
Exploring the Impact of the Covid-19 Pandemic on Health-Related Behaviours: A Person-Centred Analysis of Two British Longitudinal Cohort Studies
Kiri, J., Brandt, V.
10.1101/2023.03.28.23287685 — Posted: 2023-03-29
Modelling Disease Mitigation at Mass Gatherings: A Case Study of COVID-19 at the 2022 FIFA World Cup.
Grunnill, M., Arino, J., McCarthy, Z., Bragazzi, N. L., Coudeville, L., Thommes, E., Amiche, A., Ghasemi, A., Bourouiba, L., Tofighi, M., Asgary, A., Baky-Haskuee, M., Wu, J.
10.1101/2023.03.27.23287214 — Posted: 2023-03-29
Effectiveness of nirmatrelvir-ritonavir for the treatment of patients with mild to moderate COVID-19 and at high risk of hospitalization: Systematic review and meta-analyses of observational studies
Souza, K. M., Carrasco, G., Rojas-Cortes, R., Michel Barbosa, M., Bambirra, E. H. F., Castro, J. L., Alvares-Teodoro, J.
10.1101/2023.03.27.23287621 — Posted: 2023-03-29
Transient loss and recovery of oral chemesthesis, taste and smell with COVID-19
Weir, E., Exten, C., Gerkin, R. C., Munger, S. D., Hayes, J. E.
10.1101/2023.03.27.23287763 — Posted: 2023-03-29
The effects of weather and mobility on respiratory viruses dynamics before and after the COVID-19 pandemic
varela-lasheras, i., Perfeito, L., Mesquita, S., Goncalves-Sa, J.
10.1101/2023.03.28.23287799 — Posted: 2023-03-29
Deep repertoire mining uncovers ultra-broad coronavirus neutralizing antibodies targeting multiple epitopes
Hurtado, J., Rogers, T. F., Jaffe, D. B., Adams, B., Bangaru, S., Garcia, E., Capozzola, T., Messmer, T., Sharma, P., Song, G., Beutler, N., He, W., Dueker, K., Musharrafieh, R., Stubbington, M. T. J., Burton, D., Andrabi, R., Ward, A., McDonnell, W. J., Briney, B.
10.1101/2023.03.28.534602 — Posted: 2023-03-29
ACEI or not to ACEI: Review on using ACEI and ARBs on COVID-19 patients
Walia, R.
10.1101/2023.03.25.23287550 — Posted: 2023-03-29
Factors associated with acceptanceof COVID-19 vaccination among women in Guinea: Analysis of the first vaccination phase in March 2021.
Toure, A. A., Barry, I., MAGASSOUBA, A. S., BAH, K., Cisse, D., Sylla, Y., Camara, A. Y., LOUA, G., DIALLO, A.
10.1101/2023.03.27.23287835 — Posted: 2023-03-29

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).